New Delhi:In a move to safeguard public health, the Delhi government has banned the sale, purchase and distribution of Coldrif cough syrup after it was declared not of standard quality by the Government Analyst, Drug Testing Laboratory, Food and Drugs Administration, Madhya Pradesh. The aforementioned drug formulation is reported to be adulterated, as it contains Diethylene Glycol (46.28% w/v), which makes the drug formulation injurious to health. Read also:Contaminated Cough syrup tragedy: Sresen Pharma owner remanded in 10-day police custody
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!